Skip to main content

News

Main content
Research news

Research on Alzheimer's disease and neurodegenerative diseases is steadily progressing. In this section you will find various news items that make up the current news in this field, in Switzerland and around the world.

The ‘Pulsations’ podcast talks about caring for people suffering from dementia

An episode of the ‘Pulsations’ podcast looks at how dementia is treated at Geneva University Hospitals.

PREDICTOM: using artificial intelligence to detect dementia

The Memory Centre at Geneva University Hospitals is a partner in a major European project called PREDICTOM. Its aim is to set up a platform for screening for dementia before the first symptoms appear. 

New perspectives on understanding, preventing and treating vascular dementia

The study by Prof Zekry and her team highlights the key role of a brain molecule, the chemokine receptor 5 (CCR5), in the neuronal death observed during the development of vascular dementia.

Tau-PET: a window into the future of Alzheimer's patients

A team from the University of Geneva (UNIGE) and the University Hospitals of Geneva (HUG) has demonstrated that PET tau is capable of predicting cognitive decline in patients, better than the imaging techniques normally used.

Blood-based biomarkers for Alzheimer’s disease could greatly simplify diagnosis and reduce costs

Amyloid and tau blood-based biomarkers are highly correlated with the corresponding biomarkers used so far for the diagnosis of Alzheimer’s disease.

An action plan to prevent Alzheimer’s disease

As the population ages, the number of people with Alzheimer's disease in Europe will double by 2050A task force led by the UNIGE and the HUG is laying the foundations for a preventive protocol.

Dernière mise à jour : 11/08/2022